Who Paid My Doc
A Phase III double-blind, randomised, placebo-controlled trial to evaluate liver-related clinical outcomes and safety of once weekly injected survodutide in participants with compensated non-alcoholic steatohepatitis/metabolic dysfunction associated steatohepatitis (NASH/MASH) cirrhosis
Research payments
$11,623,742
Through program year 2025, $11,623,742 in research payments was reported against A Phase III double-blind, randomised, placebo-controlled trial to evaluate liver-related clinical outcomes and safety of once weekly injected survodutide in participants with compensated non-alcoholic steatohepatitis/metabolic dysfunction associated steatohepatitis (NASH/MASH) cirrhosis, across 5,754 payments, paid by Boehringer Ingelheim International GmbH.
- Paid by
- Boehringer Ingelheim International GmbH
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $11,623,742 | 5,754 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Charles Smith Canton, OH Named on 560 payments
- Guy Neff Sarasota, FL Named on 500 payments
- Aleida Hernandez Doral, FL Named on 299 payments
- Elliot Shin Las Vegas, NV Named on 208 payments
- Daniel Santillano San Antonio, TX Named on 189 payments
- Bal Bhandari Bastrop, LA Named on 186 payments
- Yaneicy Gonzalez Rojas Coral Gables, FL Named on 159 payments
- Augusto Focil Oxnard, CA Named on 155 payments
- Ronald Fogel Chesterfield, MI Named on 154 payments
- Rohit Puskoor Fort Worth, TX Named on 105 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.